MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3390/jcm14134671

Медицинская библиотека · Journal of clinical medicine · 2025

Assessment of Serum suPAR Levels in Patients with Group 1 and Group 4 Pulmonary Hypertension.

Tunçez Abdullah, Yalçın Muhammed Ulvi, Tezcan Hüseyin, Altunkeser Bülent Behlül, Öztürk Bahadır, Aydoğan Canan, Toprak Aslıhan, Polat Onur Can, Aygül Nazif, Demir Kenan, Gürses Kadri Murat, Özen Yasin, Akyürek Fikret, Tunçez Hatice Betül

СтатьяПеревод пока не подготовлен

Аннотация

Background/

Objectives

Pulmonary hypertension (PH) is a progressive disorder with high morbidity and mortality, partly driven by chronic inflammation. Soluble urokinase plasminogen activator receptor (suPAR) reflects immune activation. We evaluated whether suPAR is altered in Group 1 and Group 4 PH and its association with clinical, echocardiographic, and laboratory parameters.

Methods

We enrolled 44 PH patients (36 in Group 1, 8 in Group 4) and 45 healthy controls. All underwent clinical and echocardiographic assessments; right heart catheterization was performed in the PH patients. Serum suPAR was measured by ELISA. N-terminal pro B-type natriuretic peptide (NT-proBNP) and C-reactive protein (CRP) were also assessed.

Results

The suPAR plasma levels in the PH group were between 23.91 and 960.8 pg/mL (median: 73.14 p25: 62.77, p75: 167.13). suPAR was significantly higher in PH versus controls (73.14 [62.77-167.13] vs. 65.52 [53.06-80.91] pg/mL; p = 0.012). In logistic regression, systolic blood pressure, erythrocyte sedimentation rate, NT-proBNP, and suPAR independently predicted PH. suPAR correlated negatively with six-minute walk distance (r = -0.310) and tricuspid annular plane systolic excursion (r = -0.295) but positively with systolic pulmonary artery pressure (r = 0.241). On multivariate analysis, six-minute walk distance was the only independent correlate of suPAR (p = 0.004). suPAR levels did not differ between Group 1 and Group 4 PH.

Conclusions

suPAR is elevated in Group 1 and Group 4 PH and correlates with functional and echocardiographic indices of disease severity. Larger prospective studies are needed to determine suPAR's role in diagnosis, risk stratification, and therapeutic decision-making.

Для цитирования: Tunçez Abdullah, Yalçın Muhammed Ulvi, Tezcan Hüseyin, Altunkeser Bülent Behlül, Öztürk Bahadır, Aydoğan Canan, Toprak Aslıhan, Polat Onur Can, Aygül Nazif, Demir Kenan, Gürses Kadri Murat, Özen Yasin, Akyürek Fikret, Tunçez Hatice Betül. Assessment of Serum suPAR Levels in Patients with Group 1 and Group 4 Pulmonary Hypertension.. Journal of clinical medicine. 2025. DOI: 10.3390/jcm14134671.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.